Form 4: Biolife Solutions Director Reports Stock Transaction
Insider Transaction (Form 4)
Catherine Coste, a Director of Biolife Solutions Inc, reported a transaction in 13,871 shares of common stock on October 6, 2026.
Summary
- Disposition to the issuer: disposed of 13,871 Common Stock on October 6, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Catherine Coste — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Disposition to the issuer | Common Stock | 13,871 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Disposition to the issuer (13,871 shares) |
Keywords
insider transaction, Form 4, BLFS, BIOLIFE SOLUTIONS INC, neutral, Catherine Coste
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.